Skip to main content
Year archive

ACRUX LIMITED — 2005 filings

All 68 regulatory filings released by ACRUX LIMITED (ACR) in 2005, sourced directly from the official regulator.

68 Filings
2005 Period
2005 filings (68)
Filing Released Lang
Appendix 3B - Employee Share Option Plan 7 pages ?Kb
Regulatory Filings
2005-11-16 English
New US patent & termination of licence to Napa Biosciences 1
Regulatory Filings
2005-11-07 English
Annual General Meeting Presentation 16 pages ?Kb
Regulatory Filings
2005-11-07 English
Results of Meeting 2 pages ?Kb
Regulatory Filings
2005-11-07 English
Commitments Test Entity - First Quarter Report 5 pages ?Kb
Regulatory Filings
2005-10-26 English
Appendix 3B-Employee share option plan 7 pages ?Kb
Regulatory Filings
2005-10-25 English
Investor Presentation 23 pages ?Kb
Regulatory Filings
2005-10-18 English
Ceasing to be a substantial holder x2 3 pages ?Kb
Regulatory Filings
2005-10-12 English
Completion of enrolment in Evamist Phase 3 trial 2 pages ?Kb
Regulatory Filings
2005-10-11 English
Annual Report 84 pages ?Kb
Regulatory Filings
2005-10-09 English
Notice of Annual General Meeting 8 pages ?Kb
Regulatory Filings
2005-10-06 English
Appendix 3B - Employee Share Option Plan 7 pages ?Kb
Regulatory Filings
2005-10-04 English
Change of Director's Interest Notice 2 pages ?Kb
Regulatory Filings
2005-10-04 English
Change of Director's Interest Notice 3 pages ?Kb
Regulatory Filings
2005-10-04 English
12% stake in Acrux acquired by Orbis Mutual Funds 2 pages ?Kb
Regulatory Filings
2005-10-03 English
Becoming a substantial holder 68 pages ?Kb
Regulatory Filings
2005-10-02 English
Ceasing to be a substantial holder 2 pages ?Kb
Regulatory Filings
2005-09-29 English
Ceasing to be a substantial holder 7 pages ?Kb
Regulatory Filings
2005-09-29 English
Becoming a substantial holder 3 pages ?Kb
Regulatory Filings
2005-09-28 English
End of Phase 2 meeting with the FDA on Testosterone Spray 3 pages ?Kb
Regulatory Filings
2005-09-27 English
Four new US patents granted to Acrux 2 pages ?Kb
Regulatory Filings
2005-09-25 English
Positive Phase 2 Testosterone Spray Clinical Data 5 pages ?Kb
Regulatory Filings
2005-09-22 English
Ceasing to be a substantial holder 3 pages ?Kb
Regulatory Filings
2005-09-14 English
Restricted Securities - Release from Escrow 1 page
Regulatory Filings
2005-09-12 English
Appendix 3B: Employee Share Option Plan 7 pages ?Kb
Regulatory Filings
2005-09-07 English
Appendix 3B 7 pages ?Kb
Regulatory Filings
2005-09-07 English
Progress with Testosterone MD-Lotion for Men 5 pages ?Kb
Regulatory Filings
2005-09-06 English
Appendix 4E and 30 June 2005 Financial Report 61 pages ?Kb
Regulatory Filings
2005-08-24 English
Acrux Reports June 2005 Financial Results 4 pages ?Kb
Regulatory Filings
2005-08-24 English
Change of Director's Interest Notice 2 pages ?Kb
Regulatory Filings
2005-08-21 English
Change of Director's Interest Notice 2 pages ?Kb
Regulatory Filings
2005-08-21 English
Appendix 3B 7 pages ?Kb
Regulatory Filings
2005-08-16 English
Commitments Test Entity - Fourth Quarter Report 5 pages ?Kb
Regulatory Filings
2005-07-28 English
Change in substantial holding 8 pages ?Kb
Regulatory Filings
2005-07-27 English
Change in substantial holding 15 pages ?Kb
Regulatory Filings
2005-07-27 English
Change in substantial holding 3 pages ?Kb
Regulatory Filings
2005-07-24 English
Appendix 3B 7 pages ?Kb
Regulatory Filings
2005-06-30 English
Confirms Receipt of US$1million Licence Fee from Vivus 1
Regulatory Filings
2005-06-28 English
Positive data from Phase 1 trial of contraceptive spray 4 pages ?Kb
Regulatory Filings
2005-06-19 English
Release of Restricted Securities 1 page ?Kb
Regulatory Filings
2005-06-16 English
Acrux Senior Management Changes 1 page ?Kb
Regulatory Filings
2005-06-13 English
Quarterly Shareholder Update 15 pages ?Kb
Regulatory Filings
2005-06-08 English
Signs commercial deal for dermatology products 3 pages ?Kb
Regulatory Filings
2005-05-22 English
Appendix 3B 4 pages ?Kb
Regulatory Filings
2005-05-05 English
Appendix 3B - Employee Share Option Plan 8 pages ?Kb
Regulatory Filings
2005-05-05 English
Replacement Appendix 3B 8 pages ?Kb
Regulatory Filings
2005-05-05 English
Appoints Adam Watkinson as Chief Scientific Officer 2 pages ?Kb
Regulatory Filings
2005-05-02 English
Commitments Test Entity - Third Quarter Report 7 pages ?Kb
Regulatory Filings
2005-04-28 English
Change of Director's Interest Notice 2 pages ?Kb
Regulatory Filings
2005-04-18 English
Departure of Senior Manager 1 page ?Kb
Regulatory Filings
2005-04-12 English
Move Testosterone Deficiency Treatment in Men to Next Stage 3 pages ?Kb
Regulatory Filings
2005-04-06 English
Company Secretary Appointment 1 page ?Kb
Regulatory Filings
2005-03-31 English
Corrected securities subject to escrow 1 page ?Kb
Regulatory Filings
2005-03-28 English
Correction to Terms and Conditions of Options on Issue 1
Regulatory Filings
2005-03-28 English
Change of Director's Interest Notice 2 pages ?Kb
Regulatory Filings
2005-03-10 English
Change of Director's Interest Notice 2 pages ?Kb
Regulatory Filings
2005-03-10 English
Investor Presentation March 2005 12 pages ?Kb
Regulatory Filings
2005-03-06 English
Targets Nausea in Cancer Patients-New Transdermal Treatment 2 pages ?Kb
Regulatory Filings
2005-02-28 English
Shareholder Update: December 2004 - February 2005 14 pages ?Kb
Regulatory Filings
2005-02-28 English
Half Yearly Report 18 pages ?Kb
Regulatory Filings
2005-02-13 English
Positive data from large Phase 2b clinical trial 4 pages ?Kb
Regulatory Filings
2005-02-08 English
Media Release on Phase 2b clinical trial 4 pages ?Kb
Regulatory Filings
2005-02-08 English
Positive data from large Phase 2b clinical trial 4 pages ?Kb
Regulatory Filings
2005-02-08 English
Professor Richard Guy joins Acrux Scientific Advisory Board 2 pages ?Kb
Regulatory Filings
2005-02-02 English
Advances Transdermal Treatment for Global Severe Pain Mkt 3 pages ?Kb
Regulatory Filings
2005-01-31 English
Commitments Test Entity - Second Quarter Report 5 pages ?Kb
Regulatory Filings
2005-01-24 English
Becoming a substantial holder 3 pages ?Kb
Regulatory Filings
2005-01-11 English
Appoints General Counsel & Company Secretary 2 pages ?Kb
Regulatory Filings
2005-01-04 English